diphenyleneiodonium has been researched along with Bone Loss, Osteoclastic in 2 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, S | 1 |
| Huh, JE | 1 |
| Lee, SY | 1 |
| Shim, JK | 1 |
| Rhee, SG | 1 |
| Jeong, W | 1 |
| Chen, JR | 1 |
| Lazarenko, OP | 1 |
| Shankar, K | 1 |
| Blackburn, ML | 1 |
| Lumpkin, CK | 1 |
| Badger, TM | 1 |
| Ronis, MJ | 1 |
2 other studies available for diphenyleneiodonium and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
TRP14 inhibits osteoclast differentiation via its catalytic activity.
Topics: Acetylcysteine; Actins; Animals; Bone Resorption; Catalytic Domain; Cell Differentiation; Cell Line; | 2014 |
Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats.
Topics: Acetylcysteine; Animals; Bone Resorption; Cell Line; Enzyme Inhibitors; Estradiol; Ethanol; Female; | 2011 |